DMAC - DiaMedica Therapeutics Inc. (DMAC) Q4 2024 Earnings Call Transcript
2025-03-18 10:27:40 ET
DiaMedica Therapeutics Inc. (DMAC)
Q4 2024 Earnings Conference Call
March 18, 2025, 08:00 AM ET
Company Participants
Rick Pauls - President and CEO
Lorianne Masuoka - CMO
Scott Kellen - CFO
Conference Call Participants
Thomas Flaten - Lake Street
Chase Knickerbocker - Craig-Hallum
Matthew Caufield - H.C. Wainwright
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2024 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investor Relations section.
Before DiaMedica proceeds with its remarks, please note that the company will be making forward-looking statements on today's call. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements. More information, including factors that could cause actual results to differ from projected results appears in the section entitled Cautionary Note regarding forward-looking statements in the company's press release issued yesterday and under the heading Risk Factors in DiaMedica's 2024 Annual Report on Form 10-K filed yesterday. DiaMedica's SEC filings are available on the SEC's website, www.sec.gov, and on its website, diamedica.com.
Please also note that any comments made on today's call speak only as of today, March 18, 2025, and may no longer be accurate at the time of any replay or transcript rereading. DiaMedica disclaims any duty to update its forward-looking statements. Following the prepared remarks, the phone lines will be open for questions....
DiaMedica Therapeutics Inc. (DMAC) Q4 2024 Earnings Call Transcript